In the world of investing and corporate finance, the Efficient Market Hypothesis (EMH) casts a long shadow. EMH states that a sufficiently liquid market reflects the “correct” price at all times. Since efficient markets factor in all known and relevant information at all times, it is therefore practically futile to attempt to predict the future direction of market prices. In other words, a blindfolded monkey throwing darts at the Wall Street Journal has about the same chance as beating the market averages as any professional investor. At one extreme, the founder of Vanguard Investments Jack Bogle revolutionized the mutual fund industry around cheap indexing, which he posited as the solution to efficient markets. At the other, Warren Buffet’s seminal essay, The Super-Investors of Graham and Doddes-ville, defends the notion that right-headed investors can carve out a significant edge [1. The Super-Investors of Graham and Doddes-ville]. In the middle, you have the greater majority of investors who will likely cede that both extremes contain some amount of the truth. Even 2013 Nobel Laureate Eugene Fama, of the University of Chicago Booth School of Business, who is credited with developing EMH, has stated that “[asset prices] are typically right and wrong about half the time” [2. The Super-Brainy Quote]. Being able to determine when they are right and when they are wrong is the holy grail to traders and investors alike. In order to investigate how correctly assets prices reflect all known information, we must develop an intuition and methodology for estimating the fair value of an asset. As we will discuss, just because a methodology is descriptive does not mean it is predictive (i.e., correlation does not imply causation). Continue reading →
After recently having completed testing on a general method of discounted cash flow (DCF) analysis for estimating a broad basket of stocks’ intrinsic values, I became more concerned with “quality”. While DCFs remain the foundation of any sound business valuation, I discovered they are highly sensitive to the assumptions and data used. Slightly changing a minute detail can drastically influence the result causing an attractive investment to all of sudden seem not so attractive and vice versa. While relative valuation methods were a natural alternative (Wall Street’s preferred choice, in fact) to circumvent the sensitivity issues, I was inclined to believe that an ability to define robust ‘quality factors’ would complement the ideological purity of the discounted cash flow approach much better. The purpose of this discussion is to demonstrate that a good company can indeed also be a good investment. Continue reading →
A lone Chinese female investor, Xingmei Zhong, d.b.a. Full Alliance International Ltd., finalized its plan to buyout all outstanding shares of YONG for $6.69 per share in cash. The deal is expected to close at the end of the first fiscal quarter of 2014 (i.e., between October and January). The buyout price reflects a 40% premium to YONG’s market price ($4.79) as of the date of the announcement on 12-Oct-2012.
At $6.25 per share, the buyout represent a 7.04% premium to market price. Investor’s looking for a relatively low-risk return on investment can engage in a risk-arbitrage trade. Investors can buy YONG now and will likely realize the differential between market and buyout price within 3 to 6 months. At the present, one could realize a 29.18% annualized return if the deal executes in 3 months; 14.20% if the deal executes in 6 months.